Two Sigma Investments
ASND icon

Two Sigma Investments’s Ascendis Pharma A/S ASND Stock Holding History

Two Sigma Investments’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$320K Buy
+1,400
New +$314K ﹤0.01% 4032

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Investments's ASND Position: Q1 2026 in Review

Two Sigma Investments reduced its Ascendis Pharma A/S (ASND) stake by 11% in Q1 2026, selling an estimated $6.18M and leaving 220,341 shares worth $50.4M. The position accounts for 0.04% of the portfolio, ranked #504.

Two Sigma Investments first reported a position in ASND in Q1 2024 and has held it in 9 quarters since. The position peaked at $52.9M in Q4 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Two Sigma Investments held 220,341 shares of Ascendis Pharma A/S worth $50.4M as of Q1 2026.
  • Two Sigma Investments sold 27,551 Ascendis Pharma A/S shares in Q1 2026, an estimated $6.18M.
  • Ascendis Pharma A/S made up 0.04% of Two Sigma Investments's portfolio in Q1 2026, its #504 holding.
  • Two Sigma Investments first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 9 quarters since.
  • Two Sigma Investments's Ascendis Pharma A/S position peaked at $52.9M in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.